Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
6.64
+0.01 (0.23%)
At close: Jan 16, 2026, 4:00 PM EST
6.77
+0.13 (2.03%)
After-hours: Jan 16, 2026, 5:37 PM EST
IMDX Employees
As of December 31, 2024, Insight Molecular Diagnostics had 49 total employees, including 46 full-time and 3 part-time employees. The number of employees increased by 3 or 6.52% compared to the previous year.
Employees
49
Change (1Y)
3
Growth (1Y)
6.52%
Revenue / Employee
$89,837
Profits / Employee
-$1,240,367
Market Cap
190.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49 | 3 | 6.52% |
| Dec 31, 2023 | 46 | -30 | -39.47% |
| Dec 31, 2022 | 76 | -39 | -33.91% |
| Dec 31, 2021 | 115 | 64 | 125.49% |
| Dec 31, 2020 | 51 | 18 | 54.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMDX News
- 5 days ago - IMDX Supports AST and ASHI STAR Working Group's Call for Decentralized Transplant Monitoring - GlobeNewsWire
- 11 days ago - iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation - GlobeNewsWire
- 12 days ago - iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch - GlobeNewsWire
- 13 days ago - iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion - GlobeNewsWire
- 2 months ago - Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch - GlobeNewsWire
- 2 months ago - iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week - GlobeNewsWire
- 3 months ago - iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch - GlobeNewsWire